Literature DB >> 19890066

FoxP3+ regulatory T cells restrain splenic extramedullary myelopoiesis via suppression of hemopoietic cytokine-producing T cells.

Jee H Lee1, Chuanwu Wang, Chang H Kim.   

Abstract

Extramedullary myelopoiesis occurs in peripheral organs such as spleen and produces many types of myeloid cells with diverse functions in response to inflammation and infection. It is increased during immune responses and chronic inflammation and is a significant factor in regulating inflammatory diseases and immunity. Increased myeloid cells are found in FoxP3-deficient mice but the mechanism has been unclear. We investigated the mechanism by which FoxP3(+) regulatory T cells regulate the extramedullary myelopoiesis. We found that Ab or genetic depletion of FoxP3(+) regulatory T cells greatly increased the number of the myeloid progenitors in spleen during immune responses. Consistently, the splenic myelopoiesis was effectively suppressed by increased numbers of natural or induced FoxP3(+) regulatory T cells. We demonstrated that myelopoiesis is positively regulated by splenic CD4(+) T cells that produce myelopoietic cytokines (GM-CSF and IL-3), and these effector CD4(+) T cells are induced from naive CD4(+) T cells in response to antigenic stimulation. FoxP3(+) regulatory T cells were able to effectively suppress the differentiation of naive T cells into myelopoietic cytokine-producing T cells. This suppression was found to be dependent on cell contact but independent of TGFbeta. Unlike splenic myelopoiesis, marrow myelopoiesis is not significantly affected by FoxP3(+) regulatory T cells. We conclude that FoxP3(+) T cells can negatively regulate splenic extramedullary myelopoiesis by suppressing the naive T cell differentiation into myelopoietic cytokine-producing CD4(+) T cells. Our results provide new insights into regulation of extramedullary myelopoiesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19890066      PMCID: PMC2792034          DOI: 10.4049/jimmunol.0901268

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  54 in total

Review 1.  Lymphocytes, lymphokines, and hematopoiesis.

Authors:  J M Garland
Journal:  Immunol Ser       Date:  1990

Review 2.  Superantigens: bacterial and viral proteins that manipulate the immune system.

Authors:  M T Scherer; L Ignatowicz; G M Winslow; J W Kappler; P Marrack
Journal:  Annu Rev Cell Biol       Date:  1993

3.  X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.

Authors:  V L Godfrey; J E Wilkinson; L B Russell
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

4.  Overwhelming postsplenectomy infection.

Authors:  M L Brigden
Journal:  West J Med       Date:  1993-03

5.  Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology.

Authors:  E Stanley; G J Lieschke; D Grail; D Metcalf; G Hodgson; J A Gall; D W Maher; J Cebon; V Sinickas; A R Dunn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

6.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis.

Authors:  G Dranoff; A D Crawford; M Sadelain; B Ream; A Rashid; R T Bronson; G R Dickersin; C J Bachurski; E L Mark; J A Whitsett
Journal:  Science       Date:  1994-04-29       Impact factor: 47.728

7.  Relative contributions of human types 1 and 2 T-helper cell-derived eosinophilotrophic cytokines to development of eosinophilia.

Authors:  E A Wierenga; B Backx; M Snoek; L Koenderman; M L Kapsenberg
Journal:  Blood       Date:  1993-09-01       Impact factor: 22.113

Review 8.  Splenic function: physiology and splenic hypofunction.

Authors:  R H Sills
Journal:  Crit Rev Oncol Hematol       Date:  1987       Impact factor: 6.312

9.  The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome.

Authors:  M F Lyon; J Peters; P H Glenister; S Ball; E Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

10.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

View more
  9 in total

Review 1.  The spatial and developmental relationships in the macrophage family.

Authors:  Filip K Swirski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07       Impact factor: 8.311

Review 2.  Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma.

Authors:  Nico Buettner; Robert Thimme
Journal:  Semin Immunopathol       Date:  2018-11-29       Impact factor: 9.623

3.  Hematopoietic progenitor cell regulation by CD4+CD25+ T cells.

Authors:  Maite Urbieta; Isabel Barao; Monica Jones; Roland Jurecic; Angela Panoskaltsis-Mortari; Bruce R Blazar; William J Murphy; Robert B Levy
Journal:  Blood       Date:  2010-03-03       Impact factor: 22.113

4.  Homeostatic and pathogenic extramedullary hematopoiesis.

Authors:  Chang H Kim
Journal:  J Blood Med       Date:  2010-03-23

5.  Severe Developmental B Lymphopoietic Defects in Foxp3-Deficient Mice are Refractory to Adoptive Regulatory T Cell Therapy.

Authors:  Julia Riewaldt; Sandra Düber; Marie Boernert; Martina Krey; Marcin Dembinski; Siegfried Weiss; Annette I Garbe; Karsten Kretschmer
Journal:  Front Immunol       Date:  2012-06-05       Impact factor: 7.561

6.  Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis.

Authors:  Kapka Miteva; Kathleen Pappritz; Muhammad El-Shafeey; Fengquan Dong; Jochen Ringe; Carsten Tschöpe; Sophie Van Linthout
Journal:  Stem Cells Transl Med       Date:  2017-01-03       Impact factor: 6.940

7.  Oxaliplatin Treatment Alters Systemic Immune Responses.

Authors:  Vanesa Stojanovska; Monica Prakash; Rachel McQuade; Sarah Fraser; Vasso Apostolopoulos; Samy Sakkal; Kulmira Nurgali
Journal:  Biomed Res Int       Date:  2019-02-18       Impact factor: 3.411

8.  Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation.

Authors:  Thibault Griseri; Brent S McKenzie; Chris Schiering; Fiona Powrie
Journal:  Immunity       Date:  2012-11-29       Impact factor: 31.745

9.  CD137 ligand reverse signaling skews hematopoiesis towards myelopoiesis during aging.

Authors:  Qianqiao Tang; Liang Kai Koh; Dongsheng Jiang; Herbert Schwarz
Journal:  Aging (Albany NY)       Date:  2013-09       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.